{
  "table_name": "pharmacogenomics",
  "table_fullname": "bigquery-public-data.open_targets_platform.pharmacogenomics",
  "column_names": [
    "データソースID",
    "データソースバージョン",
    "データ型ID",
    "方向性",
    "エビデンスレベル",
    "遺伝子型",
    "遺伝子型注釈テキスト",
    "遺伝子型ID",
    "出典ハプロタイプID",
    "ハプロタイプID",
    "文献",
    "薬理遺伝学カテゴリ",
    "出典表現型ID",
    "表現型テキスト",
    "研究ID",
    "出典ターゲットID",
    "変異機能的影響ID",
    "変異rsID",
    "直接ターゲット",
    "薬剤"
  ],
  "column_types": [
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRUCT<list ARRAY<STRUCT<element STRING>>>",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "BOOL",
    "STRUCT<list ARRAY<STRUCT<element STRUCT<drugFromSource STRING, drugId STRING>>>>"
  ],
  "nested_column_names": [
    "datasourceId データソースID",
    "datasourceVersion データソースバージョン",
    "datatypeId データ型ID",
    "directionality 方向性",
    "evidenceLevel エビデンスレベル",
    "genotype 遺伝子型",
    "genotypeAnnotationText 遺伝子型注釈テキスト",
    "genotypeId 遺伝子型ID",
    "haplotypeFromSourceId 出典元ハプロタイプID",
    "haplotypeId ハプロタイプID",
    "literature 文献",
    "literature.list 文献一覧",
    "literature.list.element 文献一覧要素",
    "pgxCategory 薬理ゲノミクスカテゴリ",
    "phenotypeFromSourceId 出典元表現型ID",
    "phenotypeText 表現型テキスト",
    "studyId 研究ID",
    "targetFromSourceId 出典元ターゲットID",
    "variantFunctionalConsequenceId 変異の機能的影響ID",
    "variantRsId 変異rsID",
    "isDirectTarget 直接標的",
    "drugs 薬剤",
    "drugs.list 薬剤一覧",
    "drugs.list.element 薬剤一覧要素",
    "drugs.list.element.drugFromSource 出典元薬剤",
    "drugs.list.element.drugId 薬剤ID"
  ],
  "nested_column_types": [
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRUCT<list ARRAY<STRUCT<element STRING>>>",
    "ARRAY<STRUCT<element STRING>>",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "BOOL",
    "STRUCT<list ARRAY<STRUCT<element STRUCT<drugFromSource STRING, drugId STRING>>>>",
    "ARRAY<STRUCT<element STRUCT<drugFromSource STRING, drugId STRING>>>",
    "STRUCT<drugFromSource STRING, drugId STRING>",
    "STRING",
    "STRING"
  ],
  "description": [
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null,
    null
  ],
  "sample_rows": [
    {
      "datasourceId データソースID": "pharmgkb",
      "datasourceVersion データソースバージョン": "2024-05-05",
      "datatypeId データ型ID": "clinical_annotation",
      "directionality 方向性": null,
      "evidenceLevel エビデンスレベル": "3",
      "genotype 遺伝子型": "GG",
      "genotypeAnnotationText 遺伝子型注釈テキスト": "Patients with the GG genotype may require an increased dose of carbamazepine as compared to patients with the AA genotype, although this is contradicted in one study. Other genetic and clinical factors may also influence dose of carbamazepine.",
      "genotypeId 遺伝子型ID": "1_225838705_A_G,G",
      "haplotypeFromSourceId 出典元ハプロタイプID": null,
      "haplotypeId ハプロタイプID": null,
      "literature 文献": {
        "list": "[{'element': '23252947'} {'element': '19620853'} {'element': '22188362'}\n {'element': '15692831'} {'element': '25495409'} {'element': '26555147'}\n {'element': '26555147'}]"
      },
      "pgxCategory 薬理ゲノミクスカテゴリ": "dosage",
      "phenotypeFromSourceId 出典元表現型ID": null,
      "phenotypeText 表現型テキスト": "increased dose of carbamazepine",
      "studyId 研究ID": "613976757",
      "targetFromSourceId 出典元ターゲットID": "ENSG00000143819",
      "variantFunctionalConsequenceId 変異の機能的影響ID": "SO_0001583",
      "variantRsId 変異rsID": "rs2234922",
      "isDirectTarget 直接標的": false,
      "drugs 薬剤": {
        "list": "[{'element': {'drugFromSource': 'carbamazepine', 'drugId': 'CHEMBL108'}}]"
      }
    },
    {
      "datasourceId データソースID": "pharmgkb",
      "datasourceVersion データソースバージョン": "2024-05-05",
      "datatypeId データ型ID": "clinical_annotation",
      "directionality 方向性": null,
      "evidenceLevel エビデンスレベル": "3",
      "genotype 遺伝子型": "AG",
      "genotypeAnnotationText 遺伝子型注釈テキスト": "Patients with the AG genotype may require an increased dose of carbamazepine as compared to patients with the AA genotype, although this is contradicted in one study. Other genetic and clinical factors may also influence dose of carbamazepine.",
      "genotypeId 遺伝子型ID": "1_225838705_A_A,G",
      "haplotypeFromSourceId 出典元ハプロタイプID": null,
      "haplotypeId ハプロタイプID": null,
      "literature 文献": {
        "list": "[{'element': '23252947'} {'element': '19620853'} {'element': '22188362'}\n {'element': '15692831'} {'element': '25495409'} {'element': '26555147'}\n {'element': '26555147'}]"
      },
      "pgxCategory 薬理ゲノミクスカテゴリ": "dosage",
      "phenotypeFromSourceId 出典元表現型ID": null,
      "phenotypeText 表現型テキスト": "increased dose of carbamazepine",
      "studyId 研究ID": "613976757",
      "targetFromSourceId 出典元ターゲットID": "ENSG00000143819",
      "variantFunctionalConsequenceId 変異の機能的影響ID": "SO_0001583",
      "variantRsId 変異rsID": "rs2234922",
      "isDirectTarget 直接標的": false,
      "drugs 薬剤": {
        "list": "[{'element': {'drugFromSource': 'carbamazepine', 'drugId': 'CHEMBL108'}}]"
      }
    },
    {
      "datasourceId データソースID": "pharmgkb",
      "datasourceVersion データソースバージョン": "2024-05-05",
      "datatypeId データ型ID": "clinical_annotation",
      "directionality 方向性": null,
      "evidenceLevel エビデンスレベル": "3",
      "genotype 遺伝子型": "AA",
      "genotypeAnnotationText 遺伝子型注釈テキスト": "Patients with the AA genotype may require a decreased dose of carbamazepine as compared to patients with the AG or GG genotype, although this is contradicted in one study. Other genetic and clinical factors may also influence dose of carbamazepine.",
      "genotypeId 遺伝子型ID": "1_225838705_A_A,A",
      "haplotypeFromSourceId 出典元ハプロタイプID": null,
      "haplotypeId ハプロタイプID": null,
      "literature 文献": {
        "list": "[{'element': '23252947'} {'element': '19620853'} {'element': '22188362'}\n {'element': '15692831'} {'element': '25495409'} {'element': '26555147'}\n {'element': '26555147'}]"
      },
      "pgxCategory 薬理ゲノミクスカテゴリ": "dosage",
      "phenotypeFromSourceId 出典元表現型ID": null,
      "phenotypeText 表現型テキスト": "decreased dose of carbamazepine",
      "studyId 研究ID": "613976757",
      "targetFromSourceId 出典元ターゲットID": "ENSG00000143819",
      "variantFunctionalConsequenceId 変異の機能的影響ID": "SO_0002073",
      "variantRsId 変異rsID": "rs2234922",
      "isDirectTarget 直接標的": false,
      "drugs 薬剤": {
        "list": "[{'element': {'drugFromSource': 'carbamazepine', 'drugId': 'CHEMBL108'}}]"
      }
    },
    {
      "datasourceId データソースID": "pharmgkb",
      "datasourceVersion データソースバージョン": "2024-05-05",
      "datatypeId データ型ID": "clinical_annotation",
      "directionality 方向性": null,
      "evidenceLevel エビデンスレベル": "3",
      "genotype 遺伝子型": "CC",
      "genotypeAnnotationText 遺伝子型注釈テキスト": "Patients with the CC genotype who are treated with carbamazepine may have an increased risk of Stevens-Johnson syndrome as compared to patients with the TT genotype. Other genetic and clinical factors may also influence a patient's risk for Stevens-Johnson syndrome with carbamazepine treatment.",
      "genotypeId 遺伝子型ID": "6_31639273_C_C,C",
      "haplotypeFromSourceId 出典元ハプロタイプID": null,
      "haplotypeId ハプロタイプID": null,
      "literature 文献": {
        "list": "[{'element': '16538176'}]"
      },
      "pgxCategory 薬理ゲノミクスカテゴリ": "toxicity",
      "phenotypeFromSourceId 出典元表現型ID": null,
      "phenotypeText 表現型テキスト": "increased risk of Stevens-Johnson syndrome",
      "studyId 研究ID": "613976848",
      "targetFromSourceId 出典元ターゲットID": "ENSG00000204463",
      "variantFunctionalConsequenceId 変異の機能的影響ID": "SO_0002073",
      "variantRsId 変異rsID": "rs750332",
      "isDirectTarget 直接標的": false,
      "drugs 薬剤": {
        "list": "[{'element': {'drugFromSource': 'carbamazepine', 'drugId': 'CHEMBL108'}}]"
      }
    },
    {
      "datasourceId データソースID": "pharmgkb",
      "datasourceVersion データソースバージョン": "2024-05-05",
      "datatypeId データ型ID": "clinical_annotation",
      "directionality 方向性": null,
      "evidenceLevel エビデンスレベル": "3",
      "genotype 遺伝子型": "CT",
      "genotypeAnnotationText 遺伝子型注釈テキスト": "Patients with the CT genotype who are treated with carbamazepine may have an increased risk of Stevens-Johnson syndrome as compared to patients with the TT genotype. Other genetic and clinical factors may also influence a patient's risk for Stevens-Johnson syndrome with carbamazepine treatment.",
      "genotypeId 遺伝子型ID": "6_31639273_C_C,T",
      "haplotypeFromSourceId 出典元ハプロタイプID": null,
      "haplotypeId ハプロタイプID": null,
      "literature 文献": {
        "list": "[{'element': '16538176'}]"
      },
      "pgxCategory 薬理ゲノミクスカテゴリ": "toxicity",
      "phenotypeFromSourceId 出典元表現型ID": null,
      "phenotypeText 表現型テキスト": "increased risk of Stevens-Johnson syndrome",
      "studyId 研究ID": "613976848",
      "targetFromSourceId 出典元ターゲットID": "ENSG00000204463",
      "variantFunctionalConsequenceId 変異の機能的影響ID": "SO_0001627",
      "variantRsId 変異rsID": "rs750332",
      "isDirectTarget 直接標的": false,
      "drugs 薬剤": {
        "list": "[{'element': {'drugFromSource': 'carbamazepine', 'drugId': 'CHEMBL108'}}]"
      }
    }
  ]
}